Cutaneous microvascular dysfunction correlates with serum LDL and sLOX-1 receptor concentrations

Microvascular Research

Volumn 85, Issue 1, 2013, Pages 112-117

  Kenney, W Larry ^a   Cannon, Joseph G ^b   Alexander, Lacy M ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; SOLUBLE OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CUTANEOUS VASCULAR CONDUCTANCE; DISEASE ASSOCIATION; DOPPLER FLOWMETRY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LIPOPROTEIN BLOOD LEVEL; MALE; MICROANGIOPATHY; MICROCIRCULATION; MICRODIALYSIS; PRIORITY JOURNAL; SKIN BLOOD FLOW; SKIN BLOOD VESSEL; SKIN CONDUCTANCE; VASODILATATION;

AGED; ATHEROSCLEROSIS; CHOLESTEROL, LDL; COHORT STUDIES; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; LASER-DOPPLER FLOWMETRY; LINEAR MODELS; LIPOPROTEINS, LDL; MALE; MICROCIRCULATION; MIDDLE AGED; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; SCAVENGER RECEPTORS, CLASS E; SKIN; TEMPERATURE; TIME FACTORS; VASODILATION;

EID: 84871714774     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2012.10.010     Document Type: Article

References (33)

1. Abahji T.N., et al. Acute hyperhomocysteinemia induces microvascular and macrovascular endothelial dysfunction. Arch. Med. Res. 2007, 38:411-416.
2. Abularrage C.J., et al. Evaluation of macrocirculatory endothelium-dependent and endothelium-independent vasoreactivity in vascular disease. Perspect. Vasc. Surg. Endovasc. Ther. 2005, 17:245-253.
3. Abularrage C.J., et al. Evaluation of the microcirculation in vascular disease. J. Vasc. Surg. 2005, 42:574-581.
4. Binggeli C., et al. Statins enhance postischemic hyperemia in the skin circulation of hypercholesterolemic patients: a monitoring test of endothelial dysfunction for clinical practice?. J. Am. Coll. Cardiol. 2003, 42:71-77.
5. Boignard A., et al. Local hyperemia to heating is impaired in secondary Raynaud's phenomenon. Arthritis Res. Ther. 2005, 7:R1103-R1112.
6. Bruning R.S., et al. Endothelial nitric oxide synthase mediates cutaneous vasodilation during local heating and is attenuated in middle-aged human skin. J. Appl. Physiol. 2012, 112:2019-2026.
7. Coulon P., et al. Impairment of skin blood flow during post-occlusive reactive hyperhemy assessed by laser Doppler flowmetry correlates with renal resistive index. J. Hum. Hypertens. 2012, 26(1):56-63. (Jan).
8. Debbabi H., et al. Noninvasive assessment of endothelial function in the skin microcirculation. Am. J. Hypertens. 2010, 23:541-546.
9. DeLong D.M., et al. A comparison of methods for the estimation of plasma low- and very low-density lipoprotein cholesterol. The Lipid Research Clinics Prevalence Study. JAMA 1986, 256:2372-2377.
10. Hayashida K., et al. Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are elevated in acute coronary syndrome: a novel marker for early diagnosis. Circulation 2005, 112:812-818.
11. Holowatz L.A., Kenney W.L. Acute localized administration of tetrahydrobiopterin and chronic systemic atorvastatin treatment restore cutaneous microvascular function in hypercholesterolaemic humans. J. Physiol. 2011, 589:4787-4797.
12. Holowatz L.A., Kenney W.L. Oral atorvastatin therapy increases nitric oxide-dependent cutaneous vasodilation in humans by decreasing ascorbate-sensitive oxidants. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011, 301:R763-R768.
13. Holowatz L.A., et al. The cutaneous circulation as a model of generalized microvascular function. J. Appl. Physiol. 2007, 105(1):370-372. (Jul).
14. Holowatz L.A., et al. Oral atorvastatin therapy restores cutaneous microvascular function by decreasing arginase activity in hypercholesterolaemic humans. J. Physiol. 2011, 589:2093-2103.
15. Kellogg D.L., et al. Endothelial nitric oxide synthase control mechanisms in the cutaneous vasculature of humans in vivo. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:H123-H129.
16. Khan F., et al. Relationship between peripheral and coronary function using laser Doppler imaging and transthoracic echocardiography. Clin. Sci. (Lond.) 2008, 115:295-300.
17. Kume N., et al. Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts prognosis after acute coronary syndrome-a pilot study. Circ. J. 2010, 74:1399-1404.
18. Mehta J.L., Li D.Y. Identification and autoregulation of receptor for OX-LDL in cultured human coronary artery endothelial cells. Biochem. Biophys. Res. Commun. 1998, 248:511-514.
19. Meisinger C., et al. Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population. Circulation 2005, 112:651-657.
20. Minson C.T., et al. Decreased nitric oxide- and axon reflex-mediated cutaneous vasodilation with age during local heating. J. Appl. Physiol. 2002, 93:1644-1649.
21. Mitra S., et al. Oxidized LDL, LOX-1 and atherosclerosis. Cardiovasc. Drugs Ther. 2011, 25:419-429.
22. Padilla J., et al. Impact of aging on conduit artery retrograde and oscillatory shear at rest and during exercise: role of nitric oxide. Hypertension 2011, 57:484-489.
23. Rossi M., Carpi A. Skin microcirculation in peripheral arterial obliterative disease. Biomed. Pharmacother. 2004, 58:427-431.
24. Rossi M., et al. Skin blood flowmotion and microvascular reactivity investigation in hypercholesterolemic patients without clinically manifest arterial diseases. Physiol. Res. 2009, 58:39-47.
25. Ryoo S., et al. OxLDL-dependent activation of arginase II is dependent on the LOX-1 receptor and downstream RhoA signaling. Atherosclerosis 2011, 214:279-287.
26. Smith C.J., et al. Upregulation of Inducible Nitric Oxide Synthase Contributes to Attenuated Cutaneous Vasodilation in Essential Hypertensive Humans. Hypertension 2011, 58(5):935-942. (Nov).
27. Sokolnicki L.A., et al. Contribution of nitric oxide to cutaneous microvascular dilation in individuals with type 2 diabetes mellitus. Am. J. Physiol. Endocrinol. Metab. 2007, 292(1):E314-E318. (Jan).
28. Stewart J., et al. Noninvasive interrogation of microvasculature for signs of endothelial dysfunction in patients with chronic renal failure. Am. J. Physiol. Heart Circ. Physiol. 2004, 287:H2687-H2696.
29. Toshima S., et al. Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease. Arterioscler. Thromb. Vasc. Biol. 2000, 20:2243-2247.
30. Uchida K., et al. Associations of atherosclerotic risk factors with oxidized low-density lipoprotein evaluated by LOX-1 ligand activity in healthy men. Clin. Chim. Acta 2011, 412:1643-1647.
31. van der Zwan L.P., et al. Circulating oxidized LDL: determinants and association with brachial flow-mediated dilation. J. Lipid Res. 2009, 50:342-349.
32. Vasankari T., et al. Oxidized LDL and thickness of carotid intima-media are associated with coronary atherosclerosis in middle-aged men: lower levels of oxidized LDL with statin therapy. Atherosclerosis 2001, 155:403-412.
33. Young C.N., et al. Pro-atherogenic shear rate patterns in the femoral artery of healthy older adults. Atherosclerosis 2010, 211:390-392.